Intact parathyrin measured in serum from patients with chronic renal failure
Bonnin, M.R.; Gonzalez, M.T.; Huguet, J.; Navarro, M.A.
Clinical Chemistry 36(1): 175-176
1990
ISSN/ISBN: 0009-9147 PMID: 2297929 Document Number: 352725
Document emailed within 1 workday
Related Documents
Minisola, S.; Pacitti, M.T.; Romagnoli, E.; Scarnecchia, L.; Carnevale, V.; Scarpiello, A.; Mazzuoli, G. 1990: Falsely normal values of intact parathyrin in serum of patients with mild primary hyperparathyroidism? Clinical Chemistry 36(5): 810-811Bonnin, M.R.; Gonzalez, M.T.; Arranz, B.; Rosel, P.; Navarro, M.A. 1988: Intact parathyrin in patients after kidney transplantation Clinical Chemistry 34(11): 2378
Digenis, G.; Hadjivassiliou, A.G.; Mayopoulou-Symvoulidis, D.; Tsaparas, N.; Symvoulidis, A. 1981: The unidentified fluorescent substance(s) in serum of patients with chronic renal failure: correlation with serum creatinine Clinical Chemistry 27(9): 1618-1619
Małecka, J.; Grzeszczak, W.; Zukowska-Szczechowska, E.; Jendryczko, A.; Baczyński, R. 1994: Levels of cadmium in serum of patients with chronic renal failure Przeglad Lekarski 51(7): 291-295
Marja-Koivula, K.; Päivi Laitinen; Risteli, J. 2012: Evaluation of IDS-iSYS Intact Parathyroid Hormone (iPTH) and Comparison to Siemens Advia Centaur® iPTH Assay in Chronic Renal Failure Patients and in Controls Clinical Laboratory 58(5-6): 403-410
Bartelik, S.; Starzyk, J.; Krajewska, R. 1992: Concentration of prealbumin, ceruloplasmin, alpha-macroglobulin and haptoglobin in blood serum of patients with chronic non-A, non-B hepatitis treated with hemodialysis for chronic renal failure Wiadomosci Lekarskie 45(19-20): 733-736
Markiewicz, K.; Walasek, L.; Lutz, W. 1972: Disorders of serum lipid and protein composition in patients with chronic renal failure Polski Tygodnik Lekarski 27(4): 131-133
Maschio, G.; Oldrizzi, L.; Rugiu, C.; Loschiavo, C. 1989: Serum lipids in patients with chronic renal failure on long-term, protein-restricted diets American Journal of Medicine 87(5n): 51N-54N
Miura, Y. 1978: Serum transferrin levels in chronic renal failure. II. the relationship between anemia and nutrition in regular hemodialysis patients Nihon Jinzo Gakkai Shi 20(3): 243-253
Burak, W.; Grzeszczak, W.; Trelewicz, P.; Zukowska-Szczechowska, E. 1996: The effect of hemodialysis on levels of beta-endorphin in serum of patients with chronic renal failure treated with erythropoietin Przeglad Lekarski 53(2): 54-57
Kozlov, V.V.; Riabov, S.I.; Dorofeeva, T.B.; von Appen, K.; Spiridonov, V.N. 1984: Effect of hemodialysis and hemosorption on blood serum level of medium-molecular components in patients with chronic renal failure Terapevticheskii Arkhiv 56(7): 77-81
Nakayama, M.; Tanno, Y.; Otsuka, Y.; Takahashi, H.; Ikeda, M.; Katoh, N.; Yokoyama, K.; Yamamoto, H.; Tokutome, G.; Hosoya, T. 2002: Effect of angiotensin II receptor antagonist (losartan) on renal function, serum potassium and blood pressure in patients with advanced renal failure: differences between patients with a serum creatinine (SCr) level higher than 3 mg/dl and those with a lower SCr level Nihon Jinzo Gakkai Shi 44(7): 530-536
Bonnin, M.R.; Gonzalez, M.T.; Navarro, M.A. 1987: Two assays of intact parathyrin compared Clinical Chemistry 33(12): 2312
González, F. 2003: Implementation of AUGE plan for chronic renal failure patients. The implementation of Universal Access and Explicit Guaranties Plan (AUGE), generates longer waiting lists among patients with chronic renal failure Revista Medica de Chile 131(5): 545-551
Hardin, T.C.; Butler, S.C.; Ross, S.; Wakeford, J.H.; Jorgensen, J.H. 1994: Comparison of ampicillin-sulbactam and ticarcillin-clavulanic acid in patients with chronic renal failure: effects of differential pharmacokinetics on serum bactericidal activity PharmacoTherapy 14(2): 147-152
Siems, W.; Carluccio, F.; Grune, T.; Jakstadt, M.; Quast, S.; Hampl, H.; Sommerburg, O. 2002: Elevated serum concentration of cardiotoxic lipid peroxidation products in chronic renal failure in relation to severity of renal anemia Clinical Nephrology 58(Suppl 1): S20-S25
Chorváthová, V.; Dzúrik, R.; Ondreicka, R.; Ozdín, L.; Nemec, R.; Cerveń, J. 1976: Effect of glucose utilization inhibitor isolated from the serum and urine of patients with chronic renal failure on the free fatty acid metabolism in rat kidney cortex slices Physiologia Bohemoslovaca 25(2): 123-127
Das, B.S.; Misra, S.K.; Rao, D.V.; Satpathy, S.R.; Bose, T.K. 1984: Serum lipid in chronic renal failure Journal of the Association of Physicians of India 32(12): 1019-1021
Okada, K.; Kuno, T.; Yanai, M.; Maeda, H.; Takahashi, S.; Hatano, M. 1988: The effects of CaCO3 on renal osteodystrophy--comparison of patients with chronic renal failure in the predialytic stage and patients undergoing maintenance hemodialysis Nihon Jinzo Gakkai Shi 30(8): 1053-1062
Legros, J.J.; Moray, D.; Fassotte, A.; Franchimont, P. 1972: Modification of the level of serum neurophysin during chronic renal failure Journal d'Urologie et de Nephrologie 78(9): 734-737